Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of “Reduce” from Brokerages

Roche Holding AG (OTCMKTS:RHHBYGet Free Report) has been assigned an average recommendation of “Reduce” from the eight brokerages that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $40.00.

Several research firms have commented on RHHBY. Deutsche Bank Aktiengesellschaft raised shares of Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th. The Goldman Sachs Group initiated coverage on Roche in a research note on Thursday, May 30th. They set a “sell” rating for the company.

Read Our Latest Analysis on Roche

Roche Trading Down 0.4 %

Shares of Roche stock opened at $33.89 on Tuesday. The company has a 50-day simple moving average of $32.78 and a two-hundred day simple moving average of $33.13. Roche has a twelve month low of $29.20 and a twelve month high of $39.92. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75.

Institutional Trading of Roche

Several hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. grew its stake in Roche by 19.8% in the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock valued at $75,000 after acquiring an additional 342 shares during the period. Bard Financial Services Inc. grew its position in Roche by 2.0% in the 1st quarter. Bard Financial Services Inc. now owns 20,200 shares of the company’s stock valued at $645,000 after purchasing an additional 400 shares during the period. SVB Wealth LLC increased its stake in Roche by 2.6% during the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock valued at $531,000 after purchasing an additional 426 shares in the last quarter. Confluence Investment Management LLC raised its holdings in Roche by 3.7% during the second quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock worth $448,000 after buying an additional 459 shares during the last quarter. Finally, Hancock Whitney Corp lifted its stake in shares of Roche by 2.4% in the first quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock valued at $926,000 after buying an additional 678 shares in the last quarter.

About Roche

(Get Free Report

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

See Also

Analyst Recommendations for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.